Have a personal or library account? Click to login
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study Cover

The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study

Open Access
|Feb 2020

Figures & Tables

Table 1

Demographic variables of infants with vaccine complications.

VariableVaccine
DPTPentavalent
SexMale5584 (53.36)9137 (52.1)
Female4880 (46.64)8399 (47.9)
LocationUrban4025 (38.47)8788 (50.04)
Rural64399 (61.53)8773 (49.96)
Table 2

The frequency of adverse events DPT vaccine and Pentavalent vaccine in different provinces of Iran.

IDProvinceFrequency of vaccination complications (%)Total
DPTPentavalent
1Mazandaran1807 (17.27)2605 (14.83)4412 (15.74)
2Qazvin1211 (11.57)1941 (11.05)3152 (11.25)
3Golestan1409 (13.47)1146 (6.53)2555 (9.12)
4Zanjan958 (9.16)1407 (8.01)2365 (8.44)
5Khuzestan1019 (9.74)1183 (6.74)2202 (7.86)
6Gilan84 (8.04)838 (4.77)1676 (5.99)
7Fars469 (4.48)994 (5.66)1463 (5.22)
8Isfahan580 (5.54)877 (4.99)1457 (5.2)
9Alborz144 (1.38)1202 (6.84)1346 (4.8)
10East Azerbaijan290 (2.77)819 (4.66)1109 (3.96)
11Khorasan Razavi331 (3.16)756 (4.3)1087 (3.88)
12Tehran255 (2.44)682 (3.88)937 (3.34)
13Sistan & Baluchestan162 (1.55)423 (2.41)585 (2.09)
14Lorestan99 (0.95)401 (2.28)500 (1.78)
15West Azerbaijan162 (1.55)250 (1.42)412 (1.47)
16Ardebil17 (0.16)379 (2.16)396 (1.41)
17Ilam161 (1.54)221 (1.26)382 (1.36)
18Yazd102 (0.97)193 (1.1)295 (1.05)
19Hamedan93 (0.89)179 (1.02)272 (0.97)
20Kermanshah48 (0.46)157 (0.89)205 (0.73)
21North Khorasan39 (0.37)143 (0.81)182 (0.65)
22Semnan46 (0.44)136 (0.77)182 (0.65)
23Kerman53 (0.51)126 (0.72)179 (0.64)
24Markazi44 (0.42)121 (0.69)165 (0.59)
25Qom41 (0.39)83 (0.47)124 (0.44)
26Kohgiluyeh & Boyer-Ahmad13 (0.12)95 (0.54)108 (0.39)
27Bushehr17 (0.16)47 (0.27)64 (0.23)
28Southern Khorasan12 (0.11)53 (0.3)64 (0.23)
29Kurdistan17 (0.16)47 (0.27)64 (0.23)
30Hormozgan21 (0.2)38 (0.22)59 (0.21)
31Chaharmahal & Bakhtiari13 (0.12)95 (0.54)108 (0.39)
32Total country10464 (100)1756 (100)28025 (100)
agh-86-1-2449-g1.png
Figure 1

Prevalence of Adverse Events Following Immunization with DPT Vaccine.

agh-86-1-2449-g2.png
Figure 2

Prevalence of Adverse Events Following Immunization with Pentavalent Vaccine.

agh-86-1-2449-g3.png
Figure 3

Comparison of Reported Adverse Events in DPT and Pentavalent Vaccines.

Table 3

The relationship between DPT and Pentavalent vaccine characteristics and their adverse events.

VariableType VaccineChi-2P-value
DPTPentavalent
Type of reactionSevere localized condition1375 (7.83)1377 (13.16)3.80.0001
High fever*4944 (28.15)4960 (47.4)
Fever1997 (11.37)120 (1.15)
Mild localized condition5564 (31.68)2018 (19.29)
Lyme abscess576 (3.28)170 (1.62)
Seizures caused by fever287 (1.63)186 (1.78)
Screaming constantly614 (3.5)605 (5.78)
Loss of consciousness91 (0.52)45 (0.43)
Paralysis of the limb3 (0.02)2 (0.02)
Diarrhea and vomiting277 (1.58)858 (8.2)
Others1833 (10.44)123 (1.18)
Complaint classificationProgramming error718 (4.4)298 (2.85)263.10.0001
Reactions to vaccines15099 (92.47)10110 (96.63)
Reaction to the injection287 (1.76)489(0.46)
Concurrency139 (0.85)4 (0.04)
Unknown85 (0.52)3 (0.03)
HospitalizationYes157 (1.5)420 (2.39)0.110.7
No10307 (98.5)17141 (61.97)
Report typeImmediate472 (4.51)966 (5.5)13.190.0001
Non-Immediate9992 (95.49)16595 (94.5)
GenderMale5584 (53.36)9137 (52.1)4.20.05
Female4880 (46.64)8399 (52.1)
LocationUrban4025 (38.47)8788 (47.9)3540.0001
Rural6439 (61.53)8773 (49.96)

[i] * High fever is defined as higher than 39c.

DOI: https://doi.org/10.5334/aogh.2449 | Journal eISSN: 2214-9996
Language: English
Published on: Feb 3, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Zaher Khazaei, Ghobad Moradi, Seyed Mohsen Zahraei, Mohammad Mehdi Gouya, Elham Goodarzi, Fateme Yaghini, Daem Roshani, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.